Braghin et al. found that AACT induced mRNA expression and released TNF-α in murine microglial cells, promoting NF-κB translocation into the nucleus in AD pathogenesis, which suggested that inhibition of AACT could be useful for the treatment of AD [36]. The gene discussed is TNF; the disease is Alzheimer disease.